This issue home

About us

Back issues

A to Z

Publications

E-mail your questions and suggestions to WellandGood@uiowa.edu

Well&Good home



   

 

Well&Good 2000, Issue 2

It all started with the pea plant

Reviewed 2004


In 1865, an Austrian monk, Gregor Mendel, studied the common pea plant. It was the beginning of the end to speculation on heredity and its effects.

Slowly, scientists learned that the genetic principles that applied to Mendel's peas also applied to humans. Even 100 years ago, people realized some diseases ran in families - men with hemophilia tended to have male relatives on their mother's side of the family with the same disease. Despite the understanding that some diseases ran in families, how the disease was transmitted from healthy parents to their children remained a mystery.

Almost 80 years later, the expression "genetic counseling" was coined and the modern concept of genetics was born. In the 1940s and 1950s, doctors and scientists began using genetic information to help families understand the role heredity plays in inherited diseases and birth defects. Genetic testing entered modern times in 1967 when amniocentesis was introduced to identify possible chromosomal and genetic abnormalities in the fetus.

Today, University of Iowa Health Care offers comprehensive genetic screening, testing and counseling to pregnant women and pre-conception counseling for couples who know of existing genetic abnormalities in their families.

Roger Williamson, M.D., obstetrics and gynecological staff physician at University of Iowa Hospitals and Clinics said screening and/or testing can be done at various stages of pregnancy.

The risk of having a child with a chromosome abnormality increases with the age of the mother. Traditionally, women age 35 years of age and older at delivery have been offered testing. If a couple wants testing under these circumstances, the options include a test performed between 10 to 12 weeks, called chorionic villus sampling (cvs) or an amniocentesis which is usually performed at 15 to 16 weeks.

Other women may opt for screening, and if this indicates a potential problem, definitive testing as indicated above can be scheduled. An ultrasound examination of the fetus may also be part of the screening process. .

The quadruple marker screen, available through the Iowa State Health Department to all pregnant women in Iowa, is conducted between 15 to 20 weeks of pregnancy. This screen can indicate an increased risk for a fetal chromosome abnormality as well as a certain types of defects such as spina bifida (opening in the spine).

Testing is becoming available which will allow screening earlier in the pregnancy, between 11 to 14 weeks. The earlier testing can be combined with the quadruple marker screen. This combined testing will decrease the number of women who are "screen positive" or whose risk is increased.

Equally important is the counseling aspect of prenatal testing. If an abnormality is found, the information must be as complete as possible. If a pregnancy continues, this gives those who will care for the baby the opportunity to provide extensive counseling before delivery. "This results in a couple who is far better prepared for the intensive care services that may be required," Williamson said.

"Counseling helps inform couples of the testing options available. Counseling also gives couples the opportunity to learn the latest information about conditions that may affect a fetus or child based on family history and other factors," he said.

If you have a health-related question, or to make an appointment, call UI Health Access - 800- 777-8442 or 384-8442.

 

dna molecules


Expanded MSAFP (Maternal Serum Alpha Fetoprotein) Screen


2000, Issue 2 home

Stress

Obesity is more than eating too much. It is lifestyle.

Listen to your mother. Cover your mouth when you cough.

Study of the pea plant is precursor of modern genetics.

New clinic opens in Iowa City

Health plans

Well&Good home

Last modification date: Fri Dec 21 11:01:31 2007
URL: http://www.uihealthcare.com /news/wellandgood/issue2/genetics.html